Correction: Therapy: Hydroxychloroquine in SLE: old drug, new perspectives [PDF]
Thomas Dörner
openalex +1 more source
Evaluation of link between COVID-19 adjacent spike in hydroxychloroquine use and increased reports of pemphigus: a disproportionality analysis of the FDA Adverse Event Reporting System. [PDF]
Baroukhian J+3 more
europepmc +1 more source
Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or Gougerot-Sjögren's disease: Prepcov multicentre trial. [PDF]
Alric L+11 more
europepmc +1 more source
Randomized Trial of Hydroxychloroquine for Newly Diagnosed Chronic Graft-versus-Host Disease in Children: A Children’s Oncology Group Study [PDF]
Andrew L. Gilman+17 more
openalex +1 more source
Hydroxychloroquine in rheumatoid arthritis [PDF]
openaire +3 more sources
Defeating lethal cancer: Interrupting the ecologic and evolutionary basis of death from malignancy
Abstract Despite the advances in cancer prevention, early detection, and treatments, all of which have led to improved cancer survival, globally, there is an increased incidence in cancer‐related deaths. Although each patient and each tumor is wholly unique, the tipping point to incurable disease is common across all patients: the dual capacity for ...
Kenneth J. Pienta+2 more
wiley +1 more source
A real-world descriptive study of screening practices for hydroxychloroquine retinopathy in Japan using an insurance claims database. [PDF]
Kato K+5 more
europepmc +1 more source
ABSTRACT Resistance to apoptosis‐inducing drugs frequently occurs in cancer cells, limiting their usefulness in ongoing cancer treatment. Despite ongoing efforts to overcome drug resistance, a definitive solution remains elusive. However, autophagy inhibition has been shown to enhance the effectiveness of some anticancer drugs and is a possible ...
Sahib Zada+3 more
wiley +1 more source
Comparison of flares in 85 patients with SLE who maintained, discontinued or reduced dose of hydroxychloroquine during a prospective study of ophthalmological screening for retinopathy (PERFOCTAPS Study). [PDF]
Marques Dias JI+11 more
europepmc +1 more source